Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 0 | 5,443,039 | +5,443,039 | $0 | $127.53M | 47.94% | +$127.53M |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 3,728,738 | +3,728,738 | $0 | $86.73M | 32.60% | +$86.73M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $22.77M | $26.09M | 9.81% | +$3.32M |
| Verve Therapeutics, Inc. | 2,008,809 | 2,008,809 | 0 | $26.68M | $9.80M | 3.69% | -$16.87M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $9.51M | $7.26M | 2.73% | -$2.25M |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $5.46M | $5.75M | 2.16% | +$291.6K |
| Unity Biotechnology, Inc. | 1,004,817 | 1,004,817 | 0 | $1.65M | $1.36M | 0.51% | -$291.4K |
| Singular Genomics Systems, Inc. | 0 | 126,630 | +126,630 | $0 | $1.07M | 0.40% | +$1.07M |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 1,444,296 | 1,444,296 | 0 | $4.43M | $431.8K | 0.16% | -$4.00M |
| Denali Therapeutics Inc.(DNLI) | 381,249 | 0 | -381,249 | $7.82M | $0 | — | -$7.82M |
| Singular Genomics Systems, Inc. | 3,798,926 | 0 | -3,798,926 | $1.95M | $0 | — | -$1.95M |